ALB and urinary bladder carcinoma: Previous studies have demonstrated that NLR, PLR, and fibrinogen are available biomarkers to predict LN metastasis (21, 27), and other hematological indicators, like MLR and ALB, have been shown to be associated with pathologic stage or LN status of bladder carcinoma (17, 27–29).